Given the dramatic increase in the survival of prostate tumor cells in HGFL+/+ TRAMP+ mice compared to those without HGFL, we next sought to examine whether STAT3 activation acts as a survival mechanism downstream of Ron signaling in prostate cancer cells ex vivo. Here, MST1R is linked to prostate carcinoma.